These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 10885469

  • 1. An orally active antidiabetic vanadyl complex, bis(1-oxy-2-pyridinethiolato)oxovanadium(IV), with VO(S2O2) coordination mode; in vitro and in vivo evaluations in rats.
    Sakurai H, Sano H, Takino T, Yasui H.
    J Inorg Biochem; 2000 May 30; 80(1-2):99-105. PubMed ID: 10885469
    [Abstract] [Full Text] [Related]

  • 2. Structure-dependent metallokinetics of antidiabetic vanadyl-picolinate complexes in rats: studies on solution structure, insulinomimetic activity, and metallokinetics.
    Yasui H, Tamura A, Takino T, Sakurai H.
    J Inorg Biochem; 2002 Jul 25; 91(1):327-38. PubMed ID: 12121792
    [Abstract] [Full Text] [Related]

  • 3. A new halogenated antidiabetic vanadyl complex, bis(5-iodopicolinato)oxovanadium(IV): in vitro and in vivo insulinomimetic evaluations and metallokinetic analysis.
    Takino T, Yasui H, Yoshitake A, Hamajima Y, Matsushita R, Takada J, Sakurai H.
    J Biol Inorg Chem; 2001 Feb 25; 6(2):133-42. PubMed ID: 11293406
    [Abstract] [Full Text] [Related]

  • 4. Orally active and long-term acting insulin-mimetic vanadyl complex:bis(picolinato)oxovanadium (IV).
    Sakurai H, Fujii K, Watanabe H, Tamura H.
    Biochem Biophys Res Commun; 1995 Sep 25; 214(3):1095-101. PubMed ID: 7575515
    [Abstract] [Full Text] [Related]

  • 5. Amelioration of insulin resistance in diabetic ob/ob mice by a new type of orally active insulin-mimetic vanadyl complex: bis(1-oxy-2-pyridinethiolato)oxovanadium(IV) with VO(S(2)O(2)) coordination mode.
    Takeshita S, Kawamura I, Yasuno T, Kimura C, Yamamoto T, Seki J, Tamura A, Sakurai H, Goto T.
    J Inorg Biochem; 2001 Jun 25; 85(2-3):179-86. PubMed ID: 11410238
    [Abstract] [Full Text] [Related]

  • 6. A new insulin-mimetic vanadyl complex, (N-pyridylmethylaspartate)oxovanadium(IV) with VO(N2O2) coordination mode, and evaluation of its effect on uptake of D-glucose by Ehrlich ascites tumour cells.
    Tawa R, Uchida K, Taniyama J, Fujisawa Y, Fujimoto S, Nagaoka T, Kanamori K, Sakurai H.
    J Pharm Pharmacol; 1999 Feb 25; 51(2):119-24. PubMed ID: 10217308
    [Abstract] [Full Text] [Related]

  • 7. Insulin-mimetic vanadyl(IV) complexes as evaluated by both glucose-uptake and inhibition of free fatty acids (FFA)-release in isolated rat adipocytes.
    Adachi Y, Sakurai H.
    Chem Pharm Bull (Tokyo); 2004 Apr 25; 52(4):428-33. PubMed ID: 15056957
    [Abstract] [Full Text] [Related]

  • 8. Bis(6-ethylpicolinato)oxovanadium(IV) complex with normoglycemic activity in KK-A(y) mice.
    Sasagawa T, Yoshikawa Y, Kawabe K, Sakurai H, Kojima Y.
    J Inorg Biochem; 2002 Jan 01; 88(1):108-12. PubMed ID: 11750032
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetic study on gastrointestinal absorption of insulinomimetic vanadyl complexes in rats by ESR spectroscopy.
    Fugono J, Yasui H, Sakurai H.
    J Pharm Pharmacol; 2001 Sep 01; 53(9):1247-55. PubMed ID: 11578107
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Vanadyl-biguanide complexes as potential synergistic insulin mimics.
    Woo LC, Yuen VG, Thompson KH, McNeill JH, Orvig C.
    J Inorg Biochem; 1999 Sep 30; 76(3-4):251-7. PubMed ID: 10605840
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Novel vanadyl complexes with quinoxaline N(1),N(4)-dioxide derivatives as potent in vitro insulin-mimetic compounds.
    Noblía P, Vieites M, Torre MH, Costa-Filho AJ, Cerecetto H, González M, Lavaggi ML, Adachi Y, Sakurai H, Gambino D.
    J Inorg Biochem; 2006 Feb 30; 100(2):281-7. PubMed ID: 16386797
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Syntheses of vanadyl and zinc(II) complexes of 1-hydroxy-4,5,6-substituted 2(1H)-pyrimidinones and their insulin-mimetic activities.
    Yamaguchi M, Wakasugi K, Saito R, Adachi Y, Yoshikawa Y, Sakurai H, Katoh A.
    J Inorg Biochem; 2006 Feb 30; 100(2):260-9. PubMed ID: 16387366
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of vanadium(IV) compounds in the treatment of diabetes: in vivo and in vitro studies with vanadyl sulfate and bis(maltolato)oxovandium(IV).
    Willsky GR, Goldfine AB, Kostyniak PJ, McNeill JH, Yang LQ, Khan HR, Crans DC.
    J Inorg Biochem; 2001 May 30; 85(1):33-42. PubMed ID: 11377693
    [Abstract] [Full Text] [Related]

  • 19. Metallokinetic analysis of disposition of vanadyl complexes as insulin-mimetics in rats using BCM-ESR method.
    Yasui H, Takechi K, Sakurai H.
    J Inorg Biochem; 2000 Feb 30; 78(3):185-96. PubMed ID: 10805174
    [Abstract] [Full Text] [Related]

  • 20. Mechanism on insulin-like action of vanadyl sulfate: studies on interaction between rat adipocytes and vanadium compounds.
    Nakai M, Watanabe H, Fujiwara C, Kakegawa H, Satoh T, Takada J, Matsushita R, Sakurai H.
    Biol Pharm Bull; 1995 May 30; 18(5):719-25. PubMed ID: 7492989
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.